{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:49:57Z","timestamp":1792651797901,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2013-09279"],"award-info":[{"award-number":["2013-09279"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021-01919"],"award-info":[{"award-number":["2021-01919"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cerebral cavernous malformation (CCM) is a neurovascular disease with symptoms such as strokes, hemorrhages and neurological deficits. With surgery being the only treatment strategy, understanding the molecular mechanisms of CCM is crucial in finding alternative therapeutic options for CCM. Neutrophil extracellular traps (NETs) were recently reported in CCM, and NETs were shown to have positive or negative effects in different disease contexts. In this study, we investigated the roles of NETs in CCM by pharmacologically inhibiting NET formation using Cl-amidine (a peptidyl arginine deiminase inhibitor). We show here that Cl-amidine treatment reduced lesion burden, coagulation and endothelial-to-mesenchymal transition. Furthermore, NETs promoted the activation of microglia and fibroblasts, leading to increased neuroinflammation and a chronic wound microenvironment in CCM. The inhibition of NET formation caused endothelial quiescence and promoted a healthier microenvironment. Our study suggests the inhibition of NETs as a potential therapeutic strategy in CCM.<\/jats:p>","DOI":"10.1038\/s44161-024-00577-y","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T05:02:35Z","timestamp":1733288555000},"page":"1549-1567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Pharmacological blocking of neutrophil extracellular traps attenuates immunothrombosis and neuroinflammation in cerebral cavernous malformation"],"prefix":"10.1038","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5742-0474","authenticated-orcid":false,"given":"Favour C.","family":"Onyeogaziri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6286-7302","authenticated-orcid":false,"given":"Maximiliano","family":"Arce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iza","family":"Erzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Rorsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8242-7937","authenticated-orcid":false,"given":"Matteo","family":"Malinverno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Orsenigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Sundell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Niemel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Laakso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3937-2816","authenticated-orcid":false,"given":"Behnam Rezai","family":"Jahromi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Karin","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1142-854X","authenticated-orcid":false,"given":"Peetra U.","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"577_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/CIRCRESAHA.121.318174","volume":"129","author":"DA Snellings","year":"2021","unstructured":"Snellings, D. A. et al. Cerebral cavernous malformation: from mechanism to therapy. Circ. Res. 129, 195\u2013215 (2021).","journal-title":"Circ. Res."},{"key":"577_CR2","first-page":"211\u2013220","volume":"59","author":"H Choquet","year":"2015","unstructured":"Choquet, H., Pawlikowska, L., Lawton, M. T. & Kim, H. Genetics of cerebral cavernous malformations: current status and future prospects. J. Neurosurg. Sci. 59, 211\u2013220 (2015).","journal-title":"J. Neurosurg. Sci."},{"key":"577_CR3","doi-asserted-by":"publisher","first-page":"69\u201375","DOI":"10.1086\/510439","volume":"80","author":"CL Liquori","year":"2007","unstructured":"Liquori, C. L. et al. Deletions in CCM2 are a common cause of cerebral cavernous malformations. Am. J. Hum. Genet. 80, 69\u201375 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"577_CR4","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1056\/NEJMoa2100440","volume":"385","author":"M Peyre","year":"2021","unstructured":"Peyre, M. et al. Somatic PIK3CA mutations in sporadic cerebral cavernous malformations. N. Engl. J. Med. 385, 996\u20131004 (2021).","journal-title":"N. Engl. J. Med."},{"key":"577_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41586-021-03562-8","volume":"594","author":"AA Ren","year":"2021","unstructured":"Ren, A. A. et al. PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism. Nature 594, 271\u2013276 (2021).","journal-title":"Nature"},{"key":"577_CR6","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1161\/CIRCRESAHA.118.313970","volume":"123","author":"MR Detter","year":"2018","unstructured":"Detter, M. R., Snellings, D. A. & Marchuk, D. A. Cerebral cavernous malformations develop through clonal expansion of mutant endothelial cells. Circ. Res. 123, 1143\u20131151 (2018).","journal-title":"Circ. Res."},{"key":"577_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.devcel.2013.08.020","volume":"26","author":"M Giannotta","year":"2013","unstructured":"Giannotta, M., Trani, M. & Dejana, E. VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Dev. Cell 26, 441\u2013454 (2013).","journal-title":"Dev. Cell"},{"key":"577_CR8","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1182\/blood.2021015350","volume":"140","author":"MA Globisch","year":"2022","unstructured":"Globisch, M. A. et al. Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation. Blood 140, 2154\u20132169 (2022).","journal-title":"Blood"},{"key":"577_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s40478-019-0789-0","volume":"7","author":"J Koskim\u00e4ki","year":"2019","unstructured":"Koskim\u00e4ki, J. et al. Transcriptome clarifies mechanisms of lesion genesis versus progression in models of Ccm3 cerebral cavernous malformations. Acta Neuropathol. Commun. 7, 132 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"577_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1182\/blood-2018-06-856062","volume":"133","author":"MA Lopez-Ramirez","year":"2019","unstructured":"Lopez-Ramirez, M. A. et al. Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice. Blood 133, 193\u2013204 (2019).","journal-title":"Blood"},{"key":"577_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature12207","volume":"498","author":"L Maddaluno","year":"2013","unstructured":"Maddaluno, L. et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 498, 492\u2013496 (2013).","journal-title":"Nature"},{"key":"577_CR12","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1038\/s41467-019-10707-x","volume":"10","author":"M Malinverno","year":"2019","unstructured":"Malinverno, M. et al. Endothelial cell clonal expansion in the development of cerebral cavernous malformations. Nat. Commun. 10, 2761 (2019).","journal-title":"Nat. Commun."},{"key":"577_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1227\/01.NEU.0000114512.59624.A5","volume":"54","author":"O Guzeloglu-Kayisli","year":"2004","unstructured":"Guzeloglu-Kayisli, O. et al. KRIT1\/cerebral cavernous malformation 1 protein localizes to vascular endothelium, astrocytes, and pyramidal cells of the adult human cerebral cortex. Neurosurgery 54, 943\u2013949 (2004).","journal-title":"Neurosurgery"},{"key":"577_CR14","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.122.321129","volume":"131","author":"CC Lai","year":"2022","unstructured":"Lai, C. C. et al. Neuroinflammation plays a critical role in cerebral cavernous malformation disease. Circ. Res. 131, 909\u2013925 (2022).","journal-title":"Circ. Res."},{"key":"577_CR15","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1073\/pnas.1012617108","volume":"108","author":"A Louvi","year":"2011","unstructured":"Louvi, A. et al. Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology. Proc. Natl Acad. Sci. USA 108, 3737\u20133742 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"577_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/01.STR.0000198835.49387.25","volume":"37","author":"A Seker","year":"2006","unstructured":"Seker, A. et al. CCM2 expression parallels that of CCM1. Stroke 37, 518\u2013523 (2006).","journal-title":"Stroke"},{"key":"577_CR17","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1227\/01.neu.0000318179.02912.ca","volume":"62","author":"G Tanriover","year":"2008","unstructured":"Tanriover, G. et al. PDCD10, the gene mutated in cerebral cavernous malformation 3, is expressed in the neurovascular unit. Neurosurgery 62, 930\u2013938 (2008).","journal-title":"Neurosurgery"},{"key":"577_CR18","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1161\/ATVBAHA.120.314586","volume":"40","author":"K Wang","year":"2020","unstructured":"Wang, K. et al. Mural cell-specific deletion of cerebral cavernous malformation 3 in the brain induces cerebral cavernous malformations. Arterioscler. Thromb. Vasc. Biol. 40, 2171\u20132186 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"577_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","volume":"131","author":"CT Esmon","year":"2005","unstructured":"Esmon, C. T. The interactions between inflammation and coagulation. Br. J. Haematol. 131, 417\u2013430 (2005).","journal-title":"Br. J. Haematol."},{"key":"577_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.freeradbiomed.2021.06.021","volume":"172","author":"A Perrelli","year":"2021","unstructured":"Perrelli, A. & Retta, S. F. Polymorphisms in genes related to oxidative stress and inflammation: emerging links with the pathogenesis and severity of cerebral cavernous malformation disease. Free Radic. Biol. Med. 172, 403\u2013417 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"577_CR21","doi-asserted-by":"crossref","unstructured":"Tu, T., Peng, Z., Ren, J. & Zhang, H. Cerebral cavernous malformation: immune and inflammatory perspectives. Front. Immunol. 13, 922281 (2022).","DOI":"10.3389\/fimmu.2022.922281"},{"key":"577_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11481-016-9670-0","volume":"11","author":"C Shi","year":"2016","unstructured":"Shi, C. et al. B-cell depletion reduces the maturation of cerebral cavernous malformations in murine models. J. Neuroimmune Pharmacol. 11, 369\u2013377 (2016).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"577_CR23","doi-asserted-by":"publisher","first-page":"eaaw3521","DOI":"10.1126\/scitranslmed.aaw3521","volume":"11","author":"AT Tang","year":"2019","unstructured":"Tang, A. T. et al. Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation. Sci. Transl. Med. 11, eaaw3521 (2019).","journal-title":"Sci. Transl. Med."},{"key":"577_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00018-022-04224-2","volume":"79","author":"ACYY Yau","year":"2022","unstructured":"Yau, A. C. Y. Y. et al. Inflammation and neutrophil extracellular traps in cerebral cavernous malformation. Cell. Mol. Life Sci. 79, 206 (2022).","journal-title":"Cell. Mol. Life Sci."},{"key":"577_CR25","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science 303, 1532\u20131535 (2004).","journal-title":"Science"},{"key":"577_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13046-021-02036-z","volume":"40","author":"L Ronchetti","year":"2021","unstructured":"Ronchetti, L. et al. Neutrophil extracellular traps in cancer: not only catching microbes. J. Exp. Clin. Cancer Res. 40, 231 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"577_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1152\/physrev.00062.2021","volume":"103","author":"M Herre","year":"2023","unstructured":"Herre, M., Cedervall, J., Mackman, N. & Olsson, A. K. Neutrophil extracellular traps in the pathology of cancer and other inflammatory diseases. Physiol. Rev. 103, 277\u2013312 (2023).","journal-title":"Physiol. Rev."},{"key":"577_CR28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/SHK.0b013e31816a6bb1","volume":"30","author":"S Margraf","year":"2008","unstructured":"Margraf, S. et al. Neutrophil-derived circulating free DNA (cf-DNA\/NETs): a potential prognostic marker for posttraumatic development of inflammatory second hit and sepsis. Shock 30, 352\u2013358 (2008).","journal-title":"Shock"},{"key":"577_CR29","first-page":"e138999","volume":"5","author":"Y Zuo","year":"2020","unstructured":"Zuo, Y. et al. Neutrophil extracellular traps in COVID-19. JCI Insight 5, e138999 (2020).","journal-title":"JCI Insight"},{"key":"577_CR30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12016-020-08804-7","volume":"61","author":"V Mutua","year":"2020","unstructured":"Mutua, V. & Gershwin, L. J. A review of neutrophil extracellular traps (NETs) in disease: potential anti-NETs therapeutics. Clin. Rev. Allergy Immunol. 61, 194\u2013211 (2020).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"577_CR31","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1021\/bi061180d","volume":"45","author":"Y Luo","year":"2006","unstructured":"Luo, Y. et al. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization. Biochemistry 45, 11727 (2006).","journal-title":"Biochemistry"},{"key":"577_CR32","doi-asserted-by":"publisher","first-page":"947\u2013956","DOI":"10.1161\/CIRCRESAHA.114.303312","volume":"114","author":"JS Knight","year":"2014","unstructured":"Knight, J. S. et al. Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis. Circ. Res. 114, 947\u2013956 (2014).","journal-title":"Circ. Res."},{"key":"577_CR33","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1152\/ajpgi.00435.2010","volume":"300","author":"AA Chumanevich","year":"2011","unstructured":"Chumanevich, A. A. et al. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor. Am. J. Physiol. Gastrointest. Liver Physiol. 300, 929\u2013938 (2011).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"577_CR34","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1172\/JCI67390","volume":"123","author":"JS Knight","year":"2013","unstructured":"Knight, J. S. et al. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J. Clin. Invest. 123, 2981\u20132993 (2013).","journal-title":"J. Clin. Invest."},{"key":"577_CR35","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.4049\/jimmunol.1001620","volume":"186","author":"VC Willis","year":"2011","unstructured":"Willis, V. C. et al. N-\u03b1-benzoyl-N5-(2-chloro-1-iminoethyl)-l-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J. Immunol. 186, 4396\u20134404 (2011).","journal-title":"J. Immunol."},{"key":"577_CR36","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.21037\/cdt.2017.11.05","volume":"7","author":"C Czaplicki","year":"2017","unstructured":"Czaplicki, C. et al. Can thrombus age guide thrombolytic therapy? Cardiovasc. Diagn. Ther. 7, S186 (2017).","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"577_CR37","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1161\/CIRCRESAHA.118.314571","volume":"125","author":"N Sorvillo","year":"2019","unstructured":"Sorvillo, N. et al. Plasma peptidylarginine deiminase IV promotes VWF-platelet string formation and accelerates thrombosis after vessel injury. Circ. Res. 125, 507\u2013519 (2019).","journal-title":"Circ. Res."},{"key":"577_CR38","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41586-021-03220-z","volume":"598","author":"V Kozareva","year":"2021","unstructured":"Kozareva, V. et al. A transcriptomic atlas of mouse cerebellar cortex comprehensively defines cell types. Nature 598, 214\u2013219 (2021).","journal-title":"Nature"},{"key":"577_CR39","doi-asserted-by":"publisher","first-page":"180160","DOI":"10.1038\/sdata.2018.160","volume":"5","author":"L He","year":"2018","unstructured":"He, L. et al. Single-cell RNA sequencing of mouse brain and lung vascular and vessel-associated cell types. Sci. Data 5, 180160 (2018).","journal-title":"Sci. Data"},{"key":"577_CR40","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature25739","volume":"554","author":"M Vanlandewijck","year":"2018","unstructured":"Vanlandewijck, M. et al. A molecular atlas of cell types and zonation in the brain vasculature. Nature 554, 475\u2013480 (2018).","journal-title":"Nature"},{"key":"577_CR41","doi-asserted-by":"publisher","first-page":"e61413","DOI":"10.7554\/eLife.61413","volume":"9","author":"F Orsenigo","year":"2020","unstructured":"Orsenigo, F. et al. Mapping endothelial-cell diversity in cerebral cavernous malformations at single-cell resolution. eLife 9, e61413 (2020).","journal-title":"eLife"},{"key":"577_CR42","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1182\/blood-2017-04-780825","volume":"130","author":"DM Coenen","year":"2017","unstructured":"Coenen, D. M., Mastenbroek, T. G. & Cosemans, J. M. E. M. Platelet interaction with activated endothelium: mechanistic insights from microfluidics. Blood 130, 2819\u20132828 (2017).","journal-title":"Blood"},{"key":"577_CR43","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1161\/ATVBAHA.118.311150","volume":"38","author":"EJ Folco","year":"2018","unstructured":"Folco, E. J. et al. Neutrophil extracellular traps induce endothelial cell activation and tissue factor production through interleukin-1\u03b1 and cathepsin G. Arterioscler. Thromb. Vasc. Biol. 38, 1901\u20131912 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"577_CR44","doi-asserted-by":"publisher","first-page":"e139570","DOI":"10.1172\/JCI139570","volume":"131","author":"MA Lopez-Ramirez","year":"2021","unstructured":"Lopez-Ramirez, M. A. et al. Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation. J. Clin. Invest. 131, e139570 (2021).","journal-title":"J. Clin. Invest."},{"key":"577_CR45","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1161\/ATVBAHA.117.309002","volume":"37","author":"E Pieterse","year":"2017","unstructured":"Pieterse, E. et al. Neutrophil extracellular traps drive endothelial-to-mesenchymal transition. Arterioscler. Thromb. Vasc. Biol. 37, 1371\u20131379 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"577_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14361","volume":"8","author":"E Dejana","year":"2017","unstructured":"Dejana, E., Hirschi, K. K. & Simons, M. The molecular basis of endothelial cell plasticity. Nat. Commun. 8, 14361 (2017).","journal-title":"Nat. Commun."},{"key":"577_CR47","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.3389\/fimmu.2019.02884","volume":"10","author":"F Denorme","year":"2019","unstructured":"Denorme, F., Vanhoorelbeke, K. & von De Meyer, S. F. Willebrand factor and platelet glycoprotein Ib: a thromboinflammatory axis in stroke. Front. Immunol. 10, 2884 (2019).","journal-title":"Front. Immunol."},{"key":"577_CR48","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/cvr\/cvx253","volume":"114","author":"C Souilhol","year":"2018","unstructured":"Souilhol, C., Harmsen, M. C., Evans, P. C. & Krenning, G. Endothelial\u2013mesenchymal transition in atherosclerosis. Cardiovasc. Res. 114, 565\u2013577 (2018).","journal-title":"Cardiovasc. Res."},{"key":"577_CR49","doi-asserted-by":"publisher","first-page":"76\u201384","DOI":"10.1091\/mbc.e16-09-0658","volume":"28","author":"W Su","year":"2017","unstructured":"Su, W. & Kowalczyk, A. P. The VE-cadherin cytoplasmic domain undergoes proteolytic processing during endocytosis. Mol. Biol. Cell 28, 76\u201384 (2017).","journal-title":"Mol. Biol. Cell"},{"key":"577_CR50","doi-asserted-by":"publisher","first-page":"e128577","DOI":"10.1172\/jci.insight.128577","volume":"4","author":"SB Lyne","year":"2019","unstructured":"Lyne, S. B. et al. Biomarkers of cavernous angioma with symptomatic hemorrhage. JCI Insight 4, e128577 (2019).","journal-title":"JCI Insight"},{"key":"577_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","volume":"16","author":"CM de Bont","year":"2018","unstructured":"de Bont, C. M., Boelens, W. C. & Pruijn, G. J. M. NETosis, complement, and coagulation: a triangular relationship. Cell. Mol. Immunol. 16, 19\u201327 (2018).","journal-title":"Cell. Mol. Immunol."},{"key":"577_CR52","doi-asserted-by":"publisher","first-page":"407","DOI":"10.12968\/jowc.2013.22.8.407","volume":"22","author":"P Bainbridge","year":"2013","unstructured":"Bainbridge, P. Wound healing and the role of fibroblasts. J. Wound Care 22, 407\u2013412 (2013).","journal-title":"J. Wound Care"},{"key":"577_CR53","doi-asserted-by":"publisher","first-page":"199\u2013210","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn, T. A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199\u2013210 (2008).","journal-title":"J. Pathol."},{"key":"577_CR54","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/ana.21404","volume":"64","author":"MA Almekhlafi","year":"2008","unstructured":"Almekhlafi, M. A., Hu, W. Y., Hill, M. D. & Auer, R. N. Calcification and endothelialization of thrombi in acute stroke. Ann. Neurol. 64, 344\u2013347 (2008).","journal-title":"Ann. Neurol."},{"key":"577_CR55","doi-asserted-by":"publisher","first-page":"387\u2013399","DOI":"10.1111\/jth.15134","volume":"19","author":"E DeRoo","year":"2021","unstructured":"DeRoo, E. et al. The role of platelets in thrombus fibrosis and vessel wall remodeling after venous thrombosis. J. Thromb. Haemost. 19, 387\u2013399 (2021).","journal-title":"J. Thromb. Haemost."},{"key":"577_CR56","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","volume":"38","author":"S Pastorekova","year":"2019","unstructured":"Pastorekova, S. & Gillies, R. J. The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond. Cancer Metastasis Rev. 38, 65\u201377 (2019).","journal-title":"Cancer Metastasis Rev."},{"key":"577_CR57","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bbrc.2016.05.146","volume":"476","author":"L Bao","year":"2016","unstructured":"Bao, L. et al. Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma. Biochem. Biophys. Res. Commun. 476, 467\u2013474 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"577_CR58","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1172\/JCI97459","volume":"128","author":"R Lugano","year":"2018","unstructured":"Lugano, R. et al. CD93 promotes \u03b21 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis. J. Clin. Invest. 128, 3280\u20133297 (2018).","journal-title":"J. Clin. Invest."},{"key":"577_CR59","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphar.2014.00123","volume":"5","author":"RT Kendall","year":"2014","unstructured":"Kendall, R. T. & Feghali-Bostwick, C. A. Fibroblasts in fibrosis: novel roles and mediators. Front. Pharmacol. 5, 123 (2014).","journal-title":"Front. Pharmacol."},{"key":"577_CR60","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/path.4359","volume":"233","author":"A Chrysanthopoulou","year":"2014","unstructured":"Chrysanthopoulou, A. et al. Neutrophil extracellular traps promote differentiation and function of fibroblasts. J. Pathol. 233, 294\u2013307 (2014).","journal-title":"J. Pathol."},{"key":"577_CR61","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.7150\/ijbs.75876","volume":"18","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. The role of IL-6 in fibrotic diseases: molecular and cellular mechanisms. Int. J. Biol. Sci. 18, 5405 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"577_CR62","first-page":"1084\u20131096","volume":"277","author":"E Faurobert","year":"2010","unstructured":"Faurobert, E. & Albiges-Rizo, C. Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction. FEBS J. 277, 1084\u20131096 (2010).","journal-title":"FEBS J."},{"key":"577_CR63","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1161\/STROKEAHA.120.029676","volume":"52","author":"J Oldenburg","year":"2021","unstructured":"Oldenburg, J. et al. Propranolol reduces the development of lesions and rescues barrier function in cerebral cavernous malformations: a preclinical study. Stroke 52, 1418\u20131427 (2021).","journal-title":"Stroke"},{"key":"577_CR64","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1093\/ndt\/gfh235","volume":"19","author":"S Lam","year":"2004","unstructured":"Lam, S., van der Geest, R. N., Verhagen, N. A. M., Daha, M. R. & van Kooten, C. Secretion of collagen type IV by human renal fibroblasts is increased by high glucose via a TGF-\u03b2-independent pathway. Nephrol. Dial. Transplant. 19, 1694\u20131701 (2004).","journal-title":"Nephrol. Dial. Transplant."},{"key":"577_CR65","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/labinvest.2015.66","volume":"95","author":"H Urushiyama","year":"2015","unstructured":"Urushiyama, H. et al. Role of \u03b11 and \u03b12 chains of type IV collagen in early fibrotic lesions of idiopathic interstitial pneumonias and migration of lung fibroblasts. Lab. Invest. 95, 872\u2013885 (2015).","journal-title":"Lab. Invest."},{"key":"577_CR66","doi-asserted-by":"publisher","first-page":"e2495","DOI":"10.1038\/cddis.2016.402","volume":"7","author":"XM Meng","year":"2016","unstructured":"Meng, X. M. et al. Inflammatory macrophages can transdifferentiate into myofibroblasts during renal fibrosis. Cell Death Dis. 7, e2495 (2016).","journal-title":"Cell Death Dis."},{"key":"577_CR67","doi-asserted-by":"publisher","first-page":"2952\u20132962","DOI":"10.1016\/j.ajpath.2011.08.036","volume":"179","author":"A Aldrich","year":"2011","unstructured":"Aldrich, A. & Kielian, T. Central nervous system fibrosis is associated with fibrocyte-like infiltrates. Am. J. Pathol. 179, 2952\u20132962 (2011).","journal-title":"Am. J. Pathol."},{"key":"577_CR68","doi-asserted-by":"publisher","first-page":"C979\u2013C988","DOI":"10.1152\/ajpcell.00368.2010","volume":"300","author":"H Wang","year":"2011","unstructured":"Wang, H. & Su, Y. Collagen IV contributes to nitric oxide-induced angiogenesis of lung endothelial cells. Am. J. Physiol. Cell Physiol. 300, C979\u2013C988 (2011).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"577_CR69","doi-asserted-by":"publisher","first-page":"8634","DOI":"10.1096\/fj.201900337R","volume":"33","author":"LF Garcia-Agudo","year":"2019","unstructured":"Garcia-Agudo, L. F. et al. Genetically induced brain inflammation by Cnp deletion transiently benefits from microglia depletion. FASEB J. 33, 8634\u20138647 (2019).","journal-title":"FASEB J."},{"key":"577_CR70","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3390\/biomedicines9121867","volume":"9","author":"W Elliott","year":"2021","unstructured":"Elliott, W. et al. PAD inhibitors as a potential treatment for SARS-CoV-2 immunothrombosis. Biomedicines 9, 1867 (2021).","journal-title":"Biomedicines"},{"key":"577_CR71","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.3390\/ijms18112258","volume":"18","author":"B Jang","year":"2017","unstructured":"Jang, B., Ishigami, A., Kim, Y. S. & Choi, E. K. The peptidylarginine deiminase inhibitor Cl-amidine suppresses inducible nitric oxide synthase expression in dendritic cells. Int. J. Mol. Sci. 18, 2258 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"577_CR72","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41467-020-20774-0","volume":"12","author":"HJ Zhou","year":"2021","unstructured":"Zhou, H. J. et al. Caveolae-mediated Tie2 signaling contributes to CCM pathogenesis in a brain endothelial cell-specific Pdcd10-deficient mouse model. Nat. Commun. 12, 504 (2021).","journal-title":"Nat. Commun."},{"key":"577_CR73","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.3390\/ijms22094492","volume":"22","author":"K Karolczak","year":"2021","unstructured":"Karolczak, K. & Watala, C. Blood platelets as an important but underrated circulating source of TGF\u03b2. Int. J. Mol. Sci. 22, 4492 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"577_CR74","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S1474-4422(19)30231-5","volume":"18","author":"SM Zuurbier","year":"2019","unstructured":"Zuurbier, S. M. et al. Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis. Lancet Neurol. 18, 935\u2013941 (2019).","journal-title":"Lancet Neurol."},{"key":"577_CR75","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41181-019-0069-0","volume":"4","author":"T Lindner","year":"2019","unstructured":"Lindner, T. et al. Targeting of activated fibroblasts for imaging and therapy. EJNMMI Radiopharm. Chem. 4, 16 (2019).","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"577_CR76","first-page":"S111","volume":"13","author":"M Zeisberg","year":"2000","unstructured":"Zeisberg, M., Strutz, F. & M\u00fcller, G. A. Role of fibroblast activation in inducing interstitial fibrosis. J. Nephrol. 13, S111\u2013S120 (2000).","journal-title":"J. Nephrol."},{"key":"577_CR77","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s13577-022-00822-1","volume":"36","author":"J Du","year":"2023","unstructured":"Du, J., Wang, N., Sun, H., Zheng, L. & Qi, X. Cl-amidine attenuates lipopolysaccharide-induced inflammation in human gingival fibroblasts via the JNK\/MAPK, NF-\u03baB, and Nrf2 signalling pathways. Hum. Cell 36, 223\u2013233 (2023).","journal-title":"Hum. Cell"},{"key":"577_CR78","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.3389\/fonc.2021.719922","volume":"11","author":"EJ Kay","year":"2021","unstructured":"Kay, E. J., Koulouras, G. & Zanivan, S. Regulation of extracellular matrix production in activated fibroblasts: roles of amino acid metabolism in collagen synthesis. Front. Oncol. 11, 3176 (2021).","journal-title":"Front. Oncol."},{"key":"577_CR79","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s12276-023-00962-w","volume":"55","author":"J Ren","year":"2023","unstructured":"Ren, J. et al. Single-cell sequencing reveals that endothelial cells, EndMT cells and mural cells contribute to the pathogenesis of cavernous malformations. Exp. Mol. Med. 55, 628\u2013642 (2023).","journal-title":"Exp. Mol. Med."}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-024-00577-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-024-00577-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-024-00577-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T03:04:53Z","timestamp":1733972693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-024-00577-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":79,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["577"],"URL":"https:\/\/doi.org\/10.1038\/s44161-024-00577-y","relation":{},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}